Improved survival in patients with peritoneal metastases from colorectal cancer: A preliminary study

British Journal of Cancer

Volumn 90, Issue 2, 2004, Pages 403-407

  Mahteme, H ^a   Hansson, J ^a   Berglund, ^a   Pahlman L ^a   Glimelius, B ^a   Nygren, P ^a   Graf, W ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Colorectal cancer; Intraperitoneal chemotherapy; Peritoneal metastases

Indexed keywords

FLUOROURACIL; FOLINIC ACID; METHOTREXATE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROGNOSIS;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; LEUCOVORIN; MALE; METHOTREXATE; MIDDLE AGED; PERITONEAL NEOPLASMS; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 1342301550     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601586     Document Type: Article

References (39)

1. Assersohn L, Norman A, Cunningham D, Benepal T, Ross PJ, Oates J. Influence of metastatic site as an additional predictor for response and outcome in advanced colorectal carcinoma. Br J Cancer 1999; 79: 1800-1805
2. Beaujard A, Glehen O, Caillot J, Francois Y, Bienvenu J, Panteix G, Garbit F, Grandclement E, Vignal J, Gilly FN. Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. Cancer 2000; 88: 2512-2519
3. Cavaliere F, Di Flippo F, Botti C, Cosimelli M, Giannarelli D, Aloe L, Arcuri E, Aromatario C, Consolo S, Callopoli A, Laurenzi L, Tedesco M, Di Angelo P, Giunta S, Cavaliere R. Peritonectomy and hyperthermic antiblastic perfusion in the treatment of peritoneal carcinomatosis. Eur J Surg Oncol 2000; 26: 486-491
4. Colorectal Cancer Collaborative Group. Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. BMJ 2000; 321: 531-551
5. Csoka K, Larsson R, Tholander B, Gerdin E, dela Torre M, Nygren P. Cytotoxic drug sensitivity testing of tumour cells from patients with ovarian carcinoma using the fluorometric microculture cytotoxicity assay (FMCA). Gynecol Oncol 1994; 54: 163-170
6. Csoka K, Nygren P, Graf W, Påhlman L, Glimelius B, Larsson R. Selective sensitivity of solid tumors to suramin in primary c of tumor cells from patients. Int J Cancer 1995; 3: 356-360
7. Culliford 4th AT, Books AD, Sharma S, Saltz LB, Schwartz GK, O'Reilly EM, Ilson DH, Kemeny NE, Kelsen DP, Guillem JG, Wong WD, Cohen AM, Paty PB. Surgical debulking and intraperitoneal chemotherapy for established peritoneal metastases from colon and appendix cancer. Ann Surg Oncol 2001; 10: 787-795
8. Cunliffe WJ, Sugarbaker PH. Gastrointestinal malignancy: rationale for adjuvant therapy using early postoperative intraperitoneal chemotherapy. Br J Surg 1989; 76: 1082-1090
9. de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, Boni C, Cortes-Funes H, Cervantes A, Freyer G, Papamichael D, Le Bail N, Louvet C, Hendler D, de Braud F, Wilson C, Morvan F, Bonetti A. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000; 18: 2938-2947
10. Douillard JY, Cunningham D, Roth AD, Navarro M, James RD, Karasek P, Jandik P, Iveson T, Carmichael J, Alaki M, Gruia G, Awad L, Rougier P. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trail. Lancet 2000; 355: 1041-1047
11. Elias D, Blot F, El Otmany A, Antoun S, Lasser P, Boige V, Rougier P, Ducreux M. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 2001; 92: 71-76
12. Germann UA. Detection of recombinant P-glycoprotein in multidrug resistant cultured cells. Mol Biotechnol 2000; 14: 131-145
13. Glimelius B. Biochemical modulation of 5-fluorouracil: a randomized comparison of sequential methotrexate, 5-fluorouracil and leucovorin versus sequential 5-fluorouracil and leucovorin in patients with advanced symptomatic colorectal cancer. The gastrointestinal tumour adjuvant therapy group. Ann Oncol 1993; 4: 235-240
14. Glimelius B, Jakobsen A, Graf W, Berglund Å, Gadeberg C, Hansen P, Kjaer M, Brunsgaard N, Sandberg E, Lindberg B, Sellstrom H, Lorentz T, Påhlman L, Gustavsson B. Bolus injection (2-4 min) versus short-term (10-20 min) infusion of 5-fluorouracil in patients with advanced colorectal cancer: a prospective randomised trial. Eur J Cancer 1998; 34: 674-678
15. Glimelius B. Palliative treatment of patients with colorectal cancer. Scand J Surg 2003; 1: 74-83
16. Graf W, Glimelius B, Påhlman L, Bergström R. Determinant of prognosis in advanced colorectal cancer. Eur J Cancer 1991; 27: 1119-1123
17. Graf W, Weiber S, Glimelius B, Jiborn H, Påhlman L, Zederfeldt B. Influence of 5-fluorouracil and folinic acid on colonic healing: an experimental study in the rat. Br J Surg 1992; 79: 825-828
18. Graf W, Ivarsson M, Gerdin B, Hellsing K, Påhlman L, Glimelius B. The influence of early postoperative intraperitoneal chemotherapy on human wound healing. J Surg Res 1994a; 57: 394-400
19. Graf W, Weiber S, Jiborn H, påhlman L, Glimelius B, Zederfeldt B. The roles of nutritional depletion and drug concentration in 5-fluorouracil induced inhibition of colonic healing. J Surg Res 1994b; 5: 452-456
20. Graf W, Westlin J-E, Påhlman L, Glimelius B. Adjuvant intraperitoneal 5-fluorouracil and intravenous leucovorin after colorectal cancer surgery: a randomized phase II placebo-controlled study. Int J Colorectal Dis 1994c; 1: 35-39
21. Hahn GM, Shiu EC. Effect of pH and elevated temperatures on the cytotoxicity of some chemotherapeurtic agents on Chinese hamster cells in vitro. Cancer Res 1983; 43: 5789-5791
22. Horsell KW, Merten S, Clingan P, King DW, Morrsis DL. Peritonectomy and intraperitoneal chemotherapy in appendix and colorectal cancer. Aust NZ J Surg 1999; 69: 729-732
23. Jacquet P, Stephens AD, Averbach AM, Chang D, Ettinghausen SE, Dalton RR, Steves MA, Sugarbaker PH. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer 1996; 77: 2622-2629
24. Keppler D, Kamisako T, Leier I, Yunhai C, Nies A, Tsujii H, Konig J. Localization, substrate specificity, and drug resistance conferred by conjugate export pumps of the MRP family. Adv Enzyme Regul 2000; 40: 339-349
25. Kong G, Braun R, Dewhirst M. Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size. Cancer Res 2000; 60: 4440-4445
26. Leunig M, Goetz AE, Dellian M, Zetterer G, Gamarra F, Jain RK, Messmer K. Interstitial fluid pressure in solid tumors following hyperthermia: possible correlation with therapeutic response. Cancer Res 1992; 52: 487-490
27. Long RTL, Spratt Jr JS, Dowling E. Pseudomyxoma peritonei. New concepts in management with a report of seventeen patients. Am J Surg 1969; 117: 162-169
28. Mahteme H, Påhlman L, Glimelius B, Graf W. Prognosis after surgery in patients with incurable rectal cancer: a population-based study. Br J Surg 1996; 83: 1116-1120
29. Nordic Gastrointestinal Tumour Adjuvant Therapy gRoup. Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. J Clin Oncol 1992; 10: 904-911
30. Ragnhammar P, Hafström L, Nygren P, Glimelius B. A systematic overview of chemotherapy effects in colorectal cancer. Acta Oncol 2001; 40: 282-308
31. Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ, Maroun JA, Ackland SP, Locker PK, Pirotta N, Elfring GL, Miller LL. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med 2000; 343: 905-914
32. Schellinx ME, von Meyenfeldt MF, Sugerbaker PH. Peritoneal carcinomatosis from adenocarcinoma of the colon. Cancer Treat Res 1996; 81: 247-260
33. Shepherd N, Baxter K, Love S. The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. Gastroenterology 1997; 112: 1096-1102
34. Spears CP, Gustavsson BG, Frösing R. Folinic acid modulation of fluorouracil: tissue kinetics of bolus administration. Invest New Drugs 1989; 7: 27-36
35. Stephens AD, Alderman R, Chang D, Edwards GD, Esquivel J, Steves M, Sugarbaker PH. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 1999; 6: 790-796
36. Sugarbaker PH, Schellinx ME, Chang D, Koslowe P, von Meyerfeldt M. Peritoneal carcinomatosis from adenocarcinoma of the colon. World J Surg 1996; 20: 585-592
37. Vaillant J-C, Nordlinger B, Deuffic S, Arnaud JP, Pelissier E, Favre JP, Jaeck D, Fourtanier G, Grandjean JP, Marre P, Letoublon C. Adjuvant intraperitoneal 5-fluorouracil in high risk colon cancer. Ann Surg 2000; 231: 449-456
38. van Ooijen B, van der Burg M, Planting A, Siersema P, Wiggers T. Surgical treatment of gastric drainage only for intestinal obstruction in patients with carcinoma of the ovary or peritoneal carcinomatosis of other origin. Surg Gynecol Obstet 1993; 176: 469-474
39. Wright SR, Boag AH, Valdimarsson G, Hipfner DR, Campling BG, Cole SP, Deeley RG. Immunohistochemical detection of multidrug resistance protein in human lung cancer and normal lung. Clin Cancer Res 1998; 4: 2279-2289